ORF K14HHV8 (AA 111-210) 抗体 (AbBy Fluor® 750)
Quick Overview for ORF K14HHV8 (AA 111-210) 抗体 (AbBy Fluor® 750) (ABIN5008050)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 111-210
-
交叉反应
- Virus
-
交叉反应 (详细)
- HHV 8 type M
-
产品特性
- Antibody is specific for: HHV 8 type M
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human HHV8/ORF K14
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- ORF K14HHV8
-
物质类
- Viral Protein
-
背景
-
Synonyms: NULL
Background: HHV8 has been found to be associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. To date there is much evidence to support a direct role for HHV8 in kaposi's sarcoma.
抗原
-